MARKET

SNTI

SNTI

Senti Bioscience
NASDAQ
3.490
+0.280
+8.72%
After Hours: 3.460 -0.03 -0.86% 19:28 03/14 EDT
OPEN
3.179
PREV CLOSE
3.210
HIGH
3.880
LOW
3.095
VOLUME
90.78K
TURNOVER
--
52 WEEK HIGH
16.94
52 WEEK LOW
1.520
MARKET CAP
16.85M
P/E (TTM)
-0.2238
1D
5D
1M
3M
1Y
5Y
1D
SENTI BIO APPOINTS FENG HSIUNG TO BOARD OF DIRECTORS
Reuters · 3d ago
Press Release: Senti Bio Appoints Feng Hsiung to Board of Directors
Dow Jones · 3d ago
Senti Biosciences Expands Board with New Appointment
TipRanks · 6d ago
Weekly Report: what happened at SNTI last week (0303-0307)?
Weekly Report · 6d ago
Weekly Report: what happened at SNTI last week (0224-0228)?
Weekly Report · 03/03 11:07
Senti Bio appoints Jay Cross as CFO
TipRanks · 02/25 13:20
*Senti Biosciences Appoints Jay Cross as CFO >SNTI
Dow Jones · 02/25 13:01
SENTI BIOSCIENCES INC - APPOINTS JAY CROSS AS CFO
Reuters · 02/25 13:00
More
About SNTI
Senti Biosciences, Inc. is a clinical-stage biotechnology company. It is developing cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. It is focused on off-the-shelf CAR-NK cell therapy programs for oncology indications. Its lead product candidate, SENTI-202, is a potential Logic Gated off-the-shelf CAR-NK cell therapy designed to selectively target and eliminate CD33 and/or FLT3 expressing hematologic malignancies, including acute myeloid leukemia, while sparing healthy bone marrow cells. Its second clinical development program is SENTI-301A, a multi-armed off-the-shelf healthy donor derived CAR-NK cell therapy. SENTI-202 has been designed to incorporate three chimeric proteins using a Logic Gated gene circuit and delivered through a single retrovirus. SENTI-301A is a multi-armed off-the-shelf healthy donor derived CAR-NK cell therapy designed for the treatment of advanced GPC3 positive tumors.

Webull offers Senti Biosciences Inc stock information, including NASDAQ: SNTI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNTI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNTI stock methods without spending real money on the virtual paper trading platform.